Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Latest News
All News
EMJ GOLD
UK pharma M&A stalled, biotech thrived in 2025
EMJ GOLD
AI and digital twins offer hope for rare disease research
EMJ GOLD
EU targets 11% clinical trial growth to reclaim R&D lead
EMJ GOLD
UCB and Refold Therapeutics strike amyloidosis deal
Latest Articles
All Articles
EMJ GOLD
5 minutes with Dr Stefanie Rau, Nestlé Health Science
Stefanie Rau, Global Medical Affairs Manager, Healthy Ageing, unpacks why it’s never too early to invest in your health.
EMJ GOLD
Pharma's 2025 climate report: ambition to execution
As pharma raced to meet climate targets in 2024-2025, it’s proving that scaling medicines doesn’t have to hurt the planet.
EMJ GOLD
Supporting better COPD care through interactive content
Explore this case study on how EMJ and PARI GmbH worked together on one of COPD care’s most persistent challenges.
EMJ GOLD
Daiichi Sankyo's Dr Michael Zaiac on moving beyond 'sick care'
Daiichi Sankyo’s Dr Michael Zaiac discusses how AI, biomarkers and targeted therapies are shaping oncology.
Latest Podcasts
All Podcasts
EMJ GOLD
The 2026 pharma forecast
Predictions you won’t want to miss from industry experts. Unpack opportunities, threats and unknowns.
EMJ GOLD
Pharma's year in review 2025
Hear from three expert voices in an end-of-year round-up as they reflect on the moments that shaped healthcare and life sciences in 2025.
EMJ GOLD
Carol Pitcher-Towner on the gender health divide
This week, Isabel sits down with Carol Pitcher-Towner, Alnylam, to unpack the gender inequities that continue to shape modern healthcare.
EMJ GOLD
Hanna Svanbäck on shaping the future of Alzheimer’s care
Isabel is joined by Hanna Svanbäck, Executive Director for Neuroscience, Eli Lilly, for a deep dive into the current and future Alzheimer’s landscape.
Latest Infographics
All Infographics
EMJ GOLD
How well do you know pharma marketing?
EMJ GOLD
Unwrap the best of pharma in 2025
EMJ GOLD
Inside the rise of HCP podcast engagement
EMJ GOLD
What HCPs want: Why interactive medical content works
We’ve noticed you’re accessing
from
North/South America.
View
View